A case of keratitis due to Acanthamoeba in New York, New York, and features of 10 cases

The Journal of Infectious Diseases
P MaA R Stevens

Abstract

A man in New York, New York, contracted keratitis caused by Acanthamoeba castellanii. The diagnosis was delayed because amoebae were not initially suspected as the infectious organism. The culture isolate and the amoebae in corneal sections were identified as A. castellanii by immunofluorescence using antiserum to plasma membranes of this species. With the rapid agar disk diffusion method, the amoebae were shown to e susceptible to pimaricin (0.5%) and resistant to greater than 1,000-micrograms/ml levels of paromomycin, polymyxin B-bacitracin-neomycin, acriflavine, 5-fluorocytosine, amphotericin B, gentamicin, and trimethoprim-sulfamethoxazole. The infection responded to treatment with pimaricin administered with several other drugs. This infection is the eighth case reported in the literature of acanthamoebic keratitis and emphasizes the need for clinicians to consider acanthamoebic infection in the differential diagnosis of eye infections that fail to respond to bacterial, fungal, and viral therapy.

Citations

Jun 1, 1983·Molecular and Biochemical Parasitology·S A BoglerT J Byers
Feb 1, 1991·Australian and New Zealand Journal of Ophthalmology·K A McClellan
Feb 1, 1991·Australian and New Zealand Journal of Ophthalmology·P R Badenoch
Nov 1, 1990·The Journal of protozoology·K Yagita, T Endo
Nov 1, 1996·The Journal of Eukaryotic Microbiology·R J GastT J Byers
Jan 1, 1984·Antimicrobial Agents and Chemotherapy·F L Schuster, N Mandel
Jun 1, 1992·Antimicrobial Agents and Chemotherapy·F L Schuster, L S Jacob
Jul 5, 2002·Clinical Microbiology Reviews·Frederick L Schuster
Oct 1, 1985·The British Journal of Ophthalmology·P WrightB R Jones
Oct 1, 1987·The British Journal of Ophthalmology·K McClellan, D J Coster
Jul 1, 1987·The British Journal of Ophthalmology·R YeohM G Falcon
Sep 15, 1985·American Journal of Ophthalmology·M B MooreG S Visvesvara
Apr 15, 1989·American Journal of Ophthalmology·J K Stehr-GreenG S Visvesvara
May 15, 1987·American Journal of Ophthalmology·E J CohenP R Laibson
Oct 1, 1986·Ophthalmology·M B MooreJ B Robin
Dec 25, 2010·The Journal of Eukaryotic Microbiology·Kathleen C GlaserRobert E Molestina
Nov 30, 2004·Veterinary Parasitology·Frederick L Schuster, Govinda S Visvesvara
Jul 1, 1986·Survey of Ophthalmology·J B RobinH E Kaufman
May 1, 1986·Australian and New Zealand Journal of Ophthalmology·T N JacksonJ M Weiner
Jun 2, 2014·Ophthalmology·Atsuko SunadaYoshinori Iwatani
Oct 7, 2014·The Journal of Eukaryotic Microbiology·Paul A FuerstMonica Crary
Sep 8, 2016·Antimicrobial Agents and Chemotherapy·Ruqaiyyah SiddiquiNaveed Ahmed Khan
Apr 16, 2002·The Korean Journal of Parasitology·Hyun-Hee Kong, Dong-Il Chung
Jun 25, 1998·The Korean Journal of Parasitology·D I ChungH H Kong
Jul 6, 2014·Culture, Medicine and Psychiatry·Rob Whitley
Jul 1, 1986·Postgraduate Medical Journal·J P Henry
Mar 1, 1985·International Ophthalmology·M HanssensC de Meunynck
Jan 4, 1988·The Medical Journal of Australia·C R HarwoodG Cherian
Dec 9, 1985·The Medical Journal of Australia·T J RousselD J Coster
Feb 15, 1990·American Journal of Ophthalmology·Y IshibashiK Ishii
Jan 1, 1993·Clinical Microbiology Reviews·R C Neafie, A M Marty
Oct 1, 1982·Applied and Environmental Microbiology·R L Tyndall, E L Domingue
Jan 1, 1991·Applied and Environmental Microbiology·C Paszko-KolvaR R Colwell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Transactions of the Royal Society of Tropical Medicine and Hygiene
H J BosC C Kok-van Alphen
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde
A Hamburg, J F De Jonckheere
The British Journal of Ophthalmology
O E LundW Dechant
© 2021 Meta ULC. All rights reserved